Product Information
OLOPATADINE HCL 0.2% EYE DROP is a generic product labeled by Cardinal Health, priced at $1.9835 per ML under NDC 70000071601. Its NADAC has been published 59 times since Aug 20, 2025.
FDA first approved this application on Dec 5, 2017.
Strength
2 mg/mL
Manufacturer
Cardinal HealthNDC
70000071601
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
OLOPATADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206087FDA Approved
12/5/2017
On Market Since
4/15/2025
Pharmacological Classes
Price Statistics
The NADAC for OLOPATADINE HCL 0.2% EYE DROP has been published 59 times since Aug 20, 2025, and over the history we have for it it has declined 8.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9835 per ML |
|---|---|
| All-time high | $2.1557 (Sep 10, 2025) |
| All-time low | $1.9835 (Sep 23, 2026) |
| 52-week high | $2.1454 |
| 52-week low | $1.9835 |
| Median price | $2.0986 |
| Average price | $2.0820 |
| Largest weekly change | -3.4% (May 20, 2026) |
| Weeks tracked | 59 |
| Tracking since | Aug 20, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
OLOPATADINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLOPATADINE HCL 0.2% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.2% EYE DROP, manufactured by Cardinal Health, is $1.9835 per ML (NDC 70000071601), effective Sep 30, 2026.
How has the price of OLOPATADINE HCL 0.2% EYE DROP changed over time?
Over the history we have for it, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has declined 8.0%. It has been tracked across 59 weekly CMS publications since Aug 20, 2025.
What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.2% EYE DROP?
Since Aug 20, 2025, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has ranged from a low of $1.9835 (Sep 23, 2026) to a high of $2.1557 (Sep 10, 2025), with a median of $2.0986 per ML.
Are there cheaper alternatives to OLOPATADINE HCL 0.2% EYE DROP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLOPATADINE HCL 0.2% EYE DROP in a comparable dosage form, but none are currently priced below it.
Who manufactures OLOPATADINE HCL 0.2% EYE DROP?
OLOPATADINE HCL 0.2% EYE DROP (NDC 70000071601) is labeled by Cardinal Health, and CMS classifies it as a generic product.